APA (7th ed.) Citation

A, V. d. V., F, M., C, T., L, v. d. B., V, R., R, V., . . . E, M. (2025). B7-H3 nanobody-based CAR T cells control multiple myeloma growth, while dual BCMA/B7-H3 CAR T cells overcome antigen escape. Journal of hematology & oncology, 18(1), 103. https://doi.org/10.1186/s13045-025-01756-5

Chicago Style (17th ed.) Citation

A, Van der Vreken, et al. "B7-H3 Nanobody-based CAR T Cells Control Multiple Myeloma Growth, While Dual BCMA/B7-H3 CAR T Cells Overcome Antigen Escape." Journal of Hematology & Oncology 18, no. 1 (2025): 103. https://doi.org/10.1186/s13045-025-01756-5.

MLA (9th ed.) Citation

A, Van der Vreken, et al. "B7-H3 Nanobody-based CAR T Cells Control Multiple Myeloma Growth, While Dual BCMA/B7-H3 CAR T Cells Overcome Antigen Escape." Journal of Hematology & Oncology, vol. 18, no. 1, 2025, p. 103, https://doi.org/10.1186/s13045-025-01756-5.